242 related articles for article (PubMed ID: 28368674)
41. Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin.
Kono K; Kojima C; Hayashi N; Nishisaka E; Kiura K; Watarai S; Harada A
Biomaterials; 2008 Apr; 29(11):1664-75. PubMed ID: 18194811
[TBL] [Abstract][Full Text] [Related]
42. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
43. Development of PEGylated carboxylic acid-modified polyamidoamine dendrimers as bone-targeting carriers for the treatment of bone diseases.
Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Kusamori K; Sakane T; Yamamoto A
J Control Release; 2017 Sep; 262():10-17. PubMed ID: 28710004
[TBL] [Abstract][Full Text] [Related]
44. Performance evaluation of PAMAM dendrimer based simvastatin formulations.
Kulhari H; Pooja D; Prajapati SK; Chauhan AS
Int J Pharm; 2011 Feb; 405(1-2):203-9. PubMed ID: 21145960
[TBL] [Abstract][Full Text] [Related]
45. Label-Free Fluorescent Poly(amidoamine) Dendrimer for Traceable and Controlled Drug Delivery.
Wang G; Fu L; Walker A; Chen X; Lovejoy DB; Hao M; Lee A; Chung R; Rizos H; Irvine M; Zheng M; Liu X; Lu Y; Shi B
Biomacromolecules; 2019 May; 20(5):2148-2158. PubMed ID: 30995832
[TBL] [Abstract][Full Text] [Related]
46. A combinatorial approach of inclusion complexation and dendrimer synthesization for effective targeting EGFR-TK.
Shende P; Patil S; Gaud RS
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():959-965. PubMed ID: 28482613
[TBL] [Abstract][Full Text] [Related]
47. Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy.
Kojima C; Toi Y; Harada A; Kono K
Bioconjug Chem; 2007; 18(3):663-70. PubMed ID: 17375896
[TBL] [Abstract][Full Text] [Related]
48. Cellular internalization and transport of biodegradable polyester dendrimers on a model of the pulmonary epithelium and their formulation in pressurized metered-dose inhalers.
Heyder RS; Zhong Q; Bazito RC; da Rocha SRP
Int J Pharm; 2017 Mar; 520(1-2):181-194. PubMed ID: 28161666
[TBL] [Abstract][Full Text] [Related]
49. Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.
Bharatwaj B; Mohammad AK; Dimovski R; Cassio FL; Bazito RC; Conti D; Fu Q; Reineke J; da Rocha SR
Mol Pharm; 2015 Mar; 12(3):826-38. PubMed ID: 25455560
[TBL] [Abstract][Full Text] [Related]
50. PEGylated thermo-sensitive poly(amidoamine) dendritic drug delivery systems.
Zhao Y; Fan X; Liu D; Wang Z
Int J Pharm; 2011 May; 409(1-2):229-36. PubMed ID: 21316434
[TBL] [Abstract][Full Text] [Related]
51. Binding analysis of antioxidant polyphenols with PAMAM nanoparticles.
Chanphai P; Tajmir-Riahi HA
J Biomol Struct Dyn; 2018 Oct; 36(13):3487-3495. PubMed ID: 29019428
[TBL] [Abstract][Full Text] [Related]
52. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.
He H; Li Y; Jia XR; Du J; Ying X; Lu WL; Lou JN; Wei Y
Biomaterials; 2011 Jan; 32(2):478-87. PubMed ID: 20934215
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of phenylbutazone and poly(amidoamine) dendrimers interactions by a combination of solubility, 2D-NOESY NMR, and isothermal titration calorimetry studies.
Yang W; Li Y; Cheng Y; Wu Q; Wen L; Xu T
J Pharm Sci; 2009 Mar; 98(3):1075-85. PubMed ID: 18680167
[TBL] [Abstract][Full Text] [Related]
54. PEGylated, NH2-terminated PAMAM dendrimers: a microscopic view from atomistic computer simulations.
Yang L; da Rocha SR
Mol Pharm; 2014 May; 11(5):1459-70. PubMed ID: 24679335
[TBL] [Abstract][Full Text] [Related]
55. The effect of PAMAM dendrimer concentration, generation size and surface functional group on the aqueous solubility of candesartan cilexetil.
Ertürk AS; Gürbüz MU; Tülü M
Pharm Dev Technol; 2017 Feb; 22(1):111-121. PubMed ID: 27484586
[TBL] [Abstract][Full Text] [Related]
56. Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.
Navath RS; Menjoge AR; Wang B; Romero R; Kannan S; Kannan RM
Biomacromolecules; 2010 Jun; 11(6):1544-63. PubMed ID: 20415504
[TBL] [Abstract][Full Text] [Related]
57. BR2 and CyLoP1 enhance in-vivo SN38 delivery using pegylated PAMAM dendrimers.
Mahmoudi A; Jaafari MR; Ramezanian N; Gholami L; Malaekeh-Nikouei B
Int J Pharm; 2019 Jun; 564():77-89. PubMed ID: 30991135
[TBL] [Abstract][Full Text] [Related]
58. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide.
Singh MK; Pooja D; Kulhari H; Jain SK; Sistla R; Chauhan AS
Eur J Pharm Sci; 2017 Jan; 96():84-92. PubMed ID: 27614111
[TBL] [Abstract][Full Text] [Related]
59. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia.
Santos SD; Xavier M; Leite DM; Moreira DA; Custódio B; Torrado M; Castro R; Leiro V; Rodrigues J; Tomás H; Pêgo AP
J Control Release; 2018 Dec; 291():65-79. PubMed ID: 30308255
[TBL] [Abstract][Full Text] [Related]
60. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]